Install
- 12articles · 30d
- 2+ day agolatest article
- Sep 8, 2026earliest in window
- 50%with images
- 40avg words
- Health & Wellness 8
- Health 6
- Medical 6
- Economy, Business & Finance 3
- Crime & Law 2
- Crime, Law & Justice 2
- Finance & Business 2
- Science & Nature 2
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Roche Gets FDA Clearance for B-Cell Lymphoma Test
2+ day, 22+ hour ago (17+ words) GenomeWeb Roche Gets FDA Clearance for B-Cell Lymphoma Test...
10x Genomics to Use Lunit’s AI-Powered Pathology Platform for Oncology Biomarker Discovery
2+ day, 18+ hour ago (26+ words) GenomeWeb 10x Genomics to Use Lunitâs AI-Powered Pathology Platform for Oncology Biomarker Discovery...
One Biosciences, Institut Curie to Develop TNBC Single-Cell Dx Assay With €3.3M in French Funding
2+ day, 22+ hour ago (32+ words) GenomeWeb One Biosciences, Institut Curie to Develop TNBC Single-Cell Dx Assay With â¬3.3M in French Funding...
Radiopharm Firm Full-Life to Launch Phase I Lung Cancer Trial in US, Australia
2+ day, 23+ hour ago (27+ words) GenomeWeb Radiopharm Firm Full-Life to Launch Phase I Lung Cancer Trial in US, Australia...
Context Therapeutics Begins Phase I Trial of Bispecific Antibody in CLDN6-Positive Tumors
3+ day, 23+ hour ago (69+ words) GenomeWeb Context Therapeutics Begins Phase I Trial of Bispecific Antibody in CLDN6-Positive Tumors NEW YORK â Context Therapeutics on Wednesday said it began treating patients in a Phase I trial of its claudin 6 (CLDN6)- and CD3 T-cell-engaging bispecific antibody, CTIM-76, in CLDN6-positive…...
BrainChild Raises $116M for Newly Launched CAR T Trial for Pediatric Glioma
3+ day, 23+ hour ago (65+ words) GenomeWeb BrainChild Raises $116M for Newly Launched CAR T Trial for Pediatric Glioma NEW YORK â Backed by $116 million in new financing, BrainChild Bio is starting a new trial of a CAR T-cell therapy for pediatric brain tumors that it hopes…...